Molecular Imaging and Updated Diagnostic Criteria in Lewy Body Dementias
- 14 August 2017
- journal article
- review article
- Published by Springer Nature in Current Neurology and Neuroscience Reports
- Vol. 17 (10) , 1-9
Abstract
Purpose of Review The aims of the study were to review recent advances in molecular imaging in the Lewy body dementias (LBD) and determine if these may support the clinical but contested temporal profile distinction between Parkinson disease (PD) with dementia (PDD) versus dementia with Lewy bodies (DLB). Recent Findings There do not appear to be major regional cerebral metabolic or neurotransmitter distinctions between PDD and DLB. However, recent studies highlight the relative discriminating roles of Alzheimer proteinopathies. PDD patients have lower cortical β-amyloid deposition than DLB. Preliminary tau PET studies suggest a gradient of increasing tau binding from cognitively normal PD (absent to lowest) to cognitively impaired PD (low) to DLB (intermediate) to Alzheimer disease (AD; highest). However, tau binding in DLB, including the medial temporal lobe, is substantially lower than in AD. Summary Alzheimer-type proteinopathies appear to be more common in DLB compared to PDD with relative but no absolute differences. Given the spectrum of overlapping pathologies, future α-synuclein ligands are expected to have the best potential to distinguish the LBD from pure AD.Keywords
This publication has 75 references indexed in Scilit:
- Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in Dementia with Lewy bodiesInternational Psychogeriatrics, 2013
- The Significance of α-Synuclein, Amyloid-β and Tau Pathologies in Parkinson's Disease Progression and Related DementiaNeurodegenerative Diseases, 2013
- In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson's diseaseParkinsonism & Related Disorders, 2013
- Pathologic Accumulation of α-Synuclein and Aβ in Parkinson Disease Patients With DementiaArchives of Neurology, 2012
- Cerebral Glucose Metabolic Features of Parkinson Disease and Incident Dementia: Longitudinal StudyJournal of Nuclear Medicine, 2011
- Assessment of mild dementia with amyloid and dopamine terminal positron emission tomographyBrain, 2011
- Striatal β-amyloid in dementia with Lewy bodies but not Parkinson’s diseaseJournal of Neural Transmission, 2011
- Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other Parkinsonian syndromesNeurobiology of Disease, 2011
- Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's DiseasesPLOS ONE, 2008
- Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsyJournal of Neurology, Neurosurgery & Psychiatry, 2007